Facts
as of Nov 17, 2026
Charting a new course. Sail Biomedicines was formed in October 2023, uniting first-in-category technologies developed in Flagship Labs. Sail’s platform..
It is hiring: 8 open roles, 1 of them posted in the last 30 days.
- Open roles
- 8Alion job postings
- Website
- sail.bio
As of Nov 17, 2026, Alion lists 8 open roles at Sail Biomedicines. The median pay stated in its open roles is $105k, across 8 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring slowly: few roles were posted lately.
Science & Research is the largest family, 78 of open roles.
1Posted in 30 days13% of open roles are fresh
0%Remote roles0 of 8
1Hiring offices
Can they hire you from United States?by your location
Likely
13 open roles are in your country: you apply locally, no move needed.
United States13On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Time to fillmedian days to close a role
Sail Biomedicines112 days
Market, same roles36 days
Alion signals0-100
Demand18
Pay41
Your chance48
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 11 then, 0 now
Where the openings areshare of open roles · trend
Science & Research78▼
Biotech22▲
Degree asked
Bachelor's Degree 57%Doctoral Degree (PhD) 43%
7 postings state a degree.
Benefits named in postingsshare of open roles
Professional development113%
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
What its postings pay, by level.
$115kMedianmarket estimate $113k
$100k – $150kTypical rangeUSD a year
$175kHighest paying roleSenior Scientist I, Analytical Sciences
Pay by levelmiddle half of stated pay, median marked · dashed: market median $113k
Senior6$105k$100k – $125k
$0$38k$75k$113k$150k
Source: the pay stated in the company's postings, normalised to USD a year
Named in the work visa registers of United States.
2H-1B filings in 12 months
$88kMedian offered salary
8Open roles in United States
In the register as Sail Biomedicines, Inc., Cambridge, MA
Other sponsors in the same field
US Department of Labor · latest filing Apr 10, 2026
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
CambridgeBusiest site
Source: office addresses in postings and company registers
Peers
Ranked #3 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)
Technologies named in job postings at Sail Biomedicines over the last 12 months, by layer, with the share of postings for each.
17Technologies in use
12Postings analysed
56/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
Sep 292026
News · pharmexec.com
Vincent Hennemand discusses using these types of therapies to develop treatments for autoimmune conditions.
Sep 292026
News · pharmexec.com
Johnson & Johnson moves to acquire Sail Biomedicines, Processa acquires Vidya Therapeutics, and Relation partners with GSK on AI-driven target discovery collaboration.
Aug 22026
News · Pulse 2.0
Johnson & Johnson has entered into strategic agreements with Sail Biomedicines to develop in vivo CAR-T therapies for immune-mediated diseases and has secured an exclusive option…
Jul 312026
News · pharmabiz.com
J&J collaborates with Sail Biomedicines to advance in vivo CAR-T programmes and transform autoimmune disease via immune reset
Jul 302026
News · YahooFinance
CAMBRIDGE, Mass., July 29, 2026--Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
Apr 272026
News · YahooFinance
CAMBRIDGE, Mass., April 27, 2026--Sail to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026
Sources: the outlets named on each headline, each story once